Skip to main content
. 2023 Feb 20;15(2):709. doi: 10.3390/pharmaceutics15020709

Table 3.

ANOVA analysis for optimization of responses.

Responses Adjusted
R2 		Predicted
R2 		Model p
Value		 Adequate
Precision		 % CV
Entrapment efficiency (Y1) 0.9901 0.9613 <0.0001 39.06 2.40
In vitro buoyancy (Y2) 0.9750 0.9167 <0.0002 25.34 7.20
Drug release Q6h (Y3) 0.9830 0.9434 <0.0001 30.15 3.82